Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes

Mokdad, 2001, The continuing epidemics of obesity and diabetes in the United States, JAMA, 286, 1195, 10.1001/jama.286.10.1195 Haffner, 2003, Epidemic obesity and the metabolic syndrome, Circulation, 108, 1541, 10.1161/01.CIR.0000088845.17586.EC Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation, 67, 968, 10.1161/01.CIR.67.5.968 Grundy, 2004, Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management, Circulation, 109, 551, 10.1161/01.CIR.0000112379.88385.67 Shimomura, 1996, Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity, Nat Med, 2, 800, 10.1038/nm0796-800 Hotamisligil, 1993, Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, 847, 10.1210/jc.83.3.847 Sartipy, 2003, Monocyte chemoattractant protein 1 in obesity and insulin resistance, Proc Natl Acad Sci USA, 100, 7265, 10.1073/pnas.1133870100 Hainault, 2002, Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) zucker rat, Am J Physiol Endocrinol Metab, 282, E59, 10.1152/ajpendo.2002.282.1.E59 Matsuzawa, 2004, Adiponectin and metabolic syndrome, Arterioscler Thromb Vasc Biol, 24, 29, 10.1161/01.ATV.0000099786.99623.EF Farooqi, 2001, Partial leptin deficiency and human adiposity, Nature, 414, 34, 10.1038/35102112 Pou, 2007, Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study, Circulation, 116, 1234, 10.1161/CIRCULATIONAHA.107.710509 Nakagami, 2003, Age, body mass index and Type 2 diabetes-associations modified by ethnicity, Diabetologia, 46, 1063, 10.1007/s00125-003-1158-9 Conus, 2007, Characteristics of metabolically obese normal-weight (MONW) subjects, Appl Physiol Nutr Metab, 32, 4, 10.1139/h06-092 Meigs, 2006, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease, J Clin Endocrinol Metab, 91, 2906, 10.1210/jc.2006-0594 Brochu, 2001, What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?, J Clin Endocrinol Metab, 86, 1020, 10.1210/jc.86.3.1020 Ruderman, 1981, The metabolically-obese, normal-weight individual, Am J Clin Nutr, 34, 1617, 10.1093/ajcn/34.8.1617 Ruderman, 1998, The metabolically obese, normal-weight individual revisited, Diabetes, 47, 699, 10.2337/diabetes.47.5.699 Dvorak, 1999, Phenotypic characteristics associated with insulin resistance in metabolically obese but normal weight young women, Diabetes, 48, 2210, 10.2337/diabetes.48.11.2210 St-Onge, 2004, Metabolic syndrome in normal weight Americans: new definition of the metabolically obese, normal-weight individual, Diabetes Care, 27, 2222, 10.2337/diacare.27.9.2222 Katsuki, 2003, Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance, Diabetes Care, 26, 2341, 10.2337/diacare.26.8.2341 Matsuzawa, 2006, The metabolic syndrome and adipocytokines, FEBS Lett, 580, 2917, 10.1016/j.febslet.2006.04.028 Pettit, 2002, Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22 (phox) in lymphoblast cell lines, J Hypertens, 20, 677, 10.1097/00004872-200204000-00025 Redon, 2003, Antioxidant activities and oxidative stress byproducts in human hypertension, Hypertension, 41, 1096, 10.1161/01.HYP.0000068370.21009.38 Ohno, 1993, Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism, J Hypertens, 11, 421, 10.1097/00004872-199304000-00013 Morii, 2005, Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men, Metabolism, 54, 370, 10.1016/j.metabol.2004.10.003 Taylor, 1982, Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance, J Clin Endocrinol Metab, 54, 919, 10.1210/jcem-54-5-919 Committee on Evaluation of Diagnostic Standards for Metabolic Syndrome, 2005, Definition and diagnostic standards for metabolic syndrome, Nippon Naika Gakkai Zasshi, 94, 794, 10.2169/naika.94.794 Examination Committee of Criteria for ‘Obesity Disease’ in Japan, 2002, Japan society for the study of obesity. New criteria for ‘obesity disease’ in Japan, Circ J, 66, 987, 10.1253/circj.66.987 Sesti, 1992, Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct, Diabetes, 41, 6, 10.2337/diabetes.41.1.6 Hartfield, 1998, Arachidonic acid activates NADPH oxidase by a direct, calmodulin-regulated mechanism, Prostaglandins Other Lipid Mediat, 56, 1, 10.1016/S0090-6980(98)00036-7 Mohazzab, 1994, NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium, Am J Physiol, 266, H2568 Liu, 1996, A simple chemiluminescence assay for determination of reactive oxygen species produced by human neutrophils, J Immunol Methods, 192, 173, 10.1016/0022-1759(96)00049-X Nakano, 1986, Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo [1,2-a] pyrazin-3-one, for estimating the ability of human granulocytes to generate O2-, Anal Biochem, 159, 363, 10.1016/0003-2697(86)90354-4 Sugioka, 1986, A chemiluminescent probe with a Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo [1,2-a] pyrazin-3-one, specific and sensitive for O2− production in phagocytizing macrophages, FEBS Lett, 197, 27, 10.1016/0014-5793(86)80291-5 Tsugane, 2002, Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I, Int J Obes Relat Metab Disord, 26, 529, 10.1038/sj.ijo.0801961 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 Fain, 2004, Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans, Endocrinology, 145, 2273, 10.1210/en.2003-1336 Hayashi, 2008, Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans, Diabetes, 57, 1269, 10.2337/db07-1378 Succurro, 2008, Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals, Obesity, 16, 1881, 10.1038/oby.2008.308 Chiu, 2000, Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function, Diabetes Care, 23, 1353, 10.2337/diacare.23.9.1353 Ng, 1995, Na+/H+ antiporter phenotype, abundance and phosphorylation of immortalized B lymphocytes from humans with hypertension, Hypertension, 25, 971, 10.1161/01.HYP.25.5.971 Nishihira, 1985, Phorbol myristate acetate receptors in human polymorphonuclear neutrophils, J Immunol, 135, 3439, 10.4049/jimmunol.135.5.3439 Morel, 1993, The O2− generating oxidase of B lymphocytes: Epstein-Barr virus-immortalized B lymphocytes as a tool for the identification of defective components of the oxidase in chronic granulomatous disease, Biochim Biophys Acta, 1182, 101, 10.1016/0925-4439(93)90159-X Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ Res, 74, 1141, 10.1161/01.RES.74.6.1141 Rajagopalan, 1996, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NAD/NADPH oxidase activation, J Clin Invest, 97, 1916, 10.1172/JCI118623 Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939 Bays, 2008, Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Rev Cardiovasc Ther, 6, 343, 10.1586/14779072.6.3.343